Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Children with multiple sclerosis should not become therapeutic hostages.
Controversies in MS: All relapsing multiple sclerosis patients should be managed at a specialist clinic - Combine the best of two worlds!
Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.
Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
[Relationship between serum erythropoietin levels and brain injury in preterm infants].
Comparison of serum Concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls.
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
Imaging of noninfectious inflammatory disorders of the spinal cord.
Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.
Contribution of EAE to understanding and treating multiple sclerosis.
Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.
Oligodendrocyte Development in the Absence of Their Target Axons In Vivo.
The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis.
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives.
Multiple sclerosis: Single mutation associated with familial progressive MS.
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
Self-induced drug intoxication in baclofen: of the calm hypotonic coma in the status epilepticus.
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.
Epileptic Phenotype of Two Siblings with Asparagine Synthesis Deficiency Mimics Neonatal Pyridoxine-Dependent Epilepsy.

Pages